|
San Leandro, CA, January 15, 2001 -- Sepragen Corporation (OTC BB: SPGNA), a
provider of patented technology and equipment for purification needs in the
nutritional and biotech industries, today announced an increase in bookings for
the fourth quarter of 2000. Bookings totaled over $600,000 which are the highest
in the last two years.
Dr. "Skip" Edmunds, Sepragen's acting CFO, commenting on this
increase, said, "Sepragen's technology is revolutionary and the price
points of the larger systems require missionary sales and service effort which
can only be obtained by a direct customer contact." Dr. Edmunds continued,
"While one data point does not make a trend, we are optimistic that this
strategy is sound and is starting to have an impact." Sepragen had
previously announced a switch from third-party distributors to a direct sales
organization in the domestic biotech market.
Sepragen is a leading supplier of separation process technology, equipment
and consumables to the biotechnology and nutraceutical industries. In addition
to its biotech drug separation business, the Company has developed patented
applications that provide large market opportunities in the food and beverage
industry, including debittering citrus juices, extracting isoflavone (plant
estrogen) from soy as well as extracting proteins from whey. The Company holds
over 14 issued patents relating to its core technology.
<Back
The statements in this release that relate to future events or
performance, statements about growth, future regulatory clearances, levels of sales and
market size and future manufacturing capacity and efficiencies are forward-looking
statements that involve risks and uncertainties, including risks associated with
uncertainties related to the development of markets for and commercial acceptance of the
company's products and services, the availability of components, competitors' product
introductions and other risks identified in the company's SEC filings. Actual results may
differ from those described in these forward-looking statements. Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak only as of the
date hereof.
|
